Spektor S et al. Low-dose aspirin prophylaxis and risk of intracranial hemorrhage in patients older than 60 years of age with mild or moderate head injury: A prospective study.

Those who took low-dose aspirin faced a 0.63% risk, meaning an additional 2 out of every 1,000 people suffered from intracerebral hemorrhage.

People who took the placebo had a 0.46% risk of having a head bleed during the combined trial periods. For those who took low-dose aspirin, the risk was 0.63%, the equivalent of an additional 2 ...

The team reports that taking low-dose "baby" aspirin or other NSAIDs along with their cancer treatment increased survival by 8% at five years in this group of patients.